Cargando…

A New Model of Salivary Pacemaker—A Proof of Concept and First Clinical Use

Background and Objectives: Saliva is of utmost importance for maintaining oral health. Management of saliva flow rate deficiency recently includes salivary neuro-electrostimulation. The aim of this paper is to present a new model of salivary pacemaker—the MICROSAL device (MD), an intelligent, miniat...

Descripción completa

Detalles Bibliográficos
Autores principales: Funieru, Cristian, Tudose, Dan Ștefan, Dobrică, Bogdan, Săndulescu, Mihai, Popovici, Ion Alexandru, Slușanschi, Emil Ioan, Croitoru, Sorin Mihai, Vrînceanu, Daniela, Bănică, Bogdan, Nicolescu, Mihnea Ioan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10535961/
https://www.ncbi.nlm.nih.gov/pubmed/37763766
http://dx.doi.org/10.3390/medicina59091647
_version_ 1785112753615142912
author Funieru, Cristian
Tudose, Dan Ștefan
Dobrică, Bogdan
Săndulescu, Mihai
Popovici, Ion Alexandru
Slușanschi, Emil Ioan
Croitoru, Sorin Mihai
Vrînceanu, Daniela
Bănică, Bogdan
Nicolescu, Mihnea Ioan
author_facet Funieru, Cristian
Tudose, Dan Ștefan
Dobrică, Bogdan
Săndulescu, Mihai
Popovici, Ion Alexandru
Slușanschi, Emil Ioan
Croitoru, Sorin Mihai
Vrînceanu, Daniela
Bănică, Bogdan
Nicolescu, Mihnea Ioan
author_sort Funieru, Cristian
collection PubMed
description Background and Objectives: Saliva is of utmost importance for maintaining oral health. Management of saliva flow rate deficiency recently includes salivary neuro-electrostimulation. The aim of this paper is to present a new model of salivary pacemaker—the MICROSAL device (MD), an intelligent, miniaturized, and implant-supported oral device used for salivary stimulation. Materials and Methods: This report presents the development, calibration, and first clinical tests which involved the MD. The novel features of this device are the pH sensor and the fact that it communicates with the patient’s smartphone, where oral wetness and pH are graphically exposed. Saliva samples were taken before and after the MD was used on a 68-year-old patient suffering from post-irradiation xerostomia, and albumin and total protein were analyzed. Results: The device uses up to 3 V and time intervals of 2 s seconds for stimulation. The total volume of all saliva samples collected during the clinical trial was almost seven times higher after the device was used. Albumin decreased from a maximum of 0.15 g/dL to 0.04 g/dL, and total proteins from 0.65 g/dL to 0.21 g/dL, after salivary stimulation. Conclusions: The MD increased saliva secretion of the patient, and we are confident it will be a good solution for future management of salivary gland hypofunction.
format Online
Article
Text
id pubmed-10535961
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-105359612023-09-29 A New Model of Salivary Pacemaker—A Proof of Concept and First Clinical Use Funieru, Cristian Tudose, Dan Ștefan Dobrică, Bogdan Săndulescu, Mihai Popovici, Ion Alexandru Slușanschi, Emil Ioan Croitoru, Sorin Mihai Vrînceanu, Daniela Bănică, Bogdan Nicolescu, Mihnea Ioan Medicina (Kaunas) Article Background and Objectives: Saliva is of utmost importance for maintaining oral health. Management of saliva flow rate deficiency recently includes salivary neuro-electrostimulation. The aim of this paper is to present a new model of salivary pacemaker—the MICROSAL device (MD), an intelligent, miniaturized, and implant-supported oral device used for salivary stimulation. Materials and Methods: This report presents the development, calibration, and first clinical tests which involved the MD. The novel features of this device are the pH sensor and the fact that it communicates with the patient’s smartphone, where oral wetness and pH are graphically exposed. Saliva samples were taken before and after the MD was used on a 68-year-old patient suffering from post-irradiation xerostomia, and albumin and total protein were analyzed. Results: The device uses up to 3 V and time intervals of 2 s seconds for stimulation. The total volume of all saliva samples collected during the clinical trial was almost seven times higher after the device was used. Albumin decreased from a maximum of 0.15 g/dL to 0.04 g/dL, and total proteins from 0.65 g/dL to 0.21 g/dL, after salivary stimulation. Conclusions: The MD increased saliva secretion of the patient, and we are confident it will be a good solution for future management of salivary gland hypofunction. MDPI 2023-09-12 /pmc/articles/PMC10535961/ /pubmed/37763766 http://dx.doi.org/10.3390/medicina59091647 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Funieru, Cristian
Tudose, Dan Ștefan
Dobrică, Bogdan
Săndulescu, Mihai
Popovici, Ion Alexandru
Slușanschi, Emil Ioan
Croitoru, Sorin Mihai
Vrînceanu, Daniela
Bănică, Bogdan
Nicolescu, Mihnea Ioan
A New Model of Salivary Pacemaker—A Proof of Concept and First Clinical Use
title A New Model of Salivary Pacemaker—A Proof of Concept and First Clinical Use
title_full A New Model of Salivary Pacemaker—A Proof of Concept and First Clinical Use
title_fullStr A New Model of Salivary Pacemaker—A Proof of Concept and First Clinical Use
title_full_unstemmed A New Model of Salivary Pacemaker—A Proof of Concept and First Clinical Use
title_short A New Model of Salivary Pacemaker—A Proof of Concept and First Clinical Use
title_sort new model of salivary pacemaker—a proof of concept and first clinical use
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10535961/
https://www.ncbi.nlm.nih.gov/pubmed/37763766
http://dx.doi.org/10.3390/medicina59091647
work_keys_str_mv AT funierucristian anewmodelofsalivarypacemakeraproofofconceptandfirstclinicaluse
AT tudosedanstefan anewmodelofsalivarypacemakeraproofofconceptandfirstclinicaluse
AT dobricabogdan anewmodelofsalivarypacemakeraproofofconceptandfirstclinicaluse
AT sandulescumihai anewmodelofsalivarypacemakeraproofofconceptandfirstclinicaluse
AT popoviciionalexandru anewmodelofsalivarypacemakeraproofofconceptandfirstclinicaluse
AT slusanschiemilioan anewmodelofsalivarypacemakeraproofofconceptandfirstclinicaluse
AT croitorusorinmihai anewmodelofsalivarypacemakeraproofofconceptandfirstclinicaluse
AT vrinceanudaniela anewmodelofsalivarypacemakeraproofofconceptandfirstclinicaluse
AT banicabogdan anewmodelofsalivarypacemakeraproofofconceptandfirstclinicaluse
AT nicolescumihneaioan anewmodelofsalivarypacemakeraproofofconceptandfirstclinicaluse
AT funierucristian newmodelofsalivarypacemakeraproofofconceptandfirstclinicaluse
AT tudosedanstefan newmodelofsalivarypacemakeraproofofconceptandfirstclinicaluse
AT dobricabogdan newmodelofsalivarypacemakeraproofofconceptandfirstclinicaluse
AT sandulescumihai newmodelofsalivarypacemakeraproofofconceptandfirstclinicaluse
AT popoviciionalexandru newmodelofsalivarypacemakeraproofofconceptandfirstclinicaluse
AT slusanschiemilioan newmodelofsalivarypacemakeraproofofconceptandfirstclinicaluse
AT croitorusorinmihai newmodelofsalivarypacemakeraproofofconceptandfirstclinicaluse
AT vrinceanudaniela newmodelofsalivarypacemakeraproofofconceptandfirstclinicaluse
AT banicabogdan newmodelofsalivarypacemakeraproofofconceptandfirstclinicaluse
AT nicolescumihneaioan newmodelofsalivarypacemakeraproofofconceptandfirstclinicaluse